Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.69

+0.02 (0.03%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

BUY

Thinks it’s time to get back in. They’re getting their act together again. Looking attractive. Great international exposure. Thinks it could be earning $2.50-$3 a share in 2 to 3 years without a lot of problem. With a 12 multiple, you are looking at a $30 plus stock along with a dividend.

COMMENT

On his watch list. Two major factors will impact this stock. As interest rates go up, the company will do much better as it will help their bottom line. Market movement t will also affect them. Too expensive for him at this point.

TOP PICK

Over the last couple of years they made significant strides in hedging out a lot of their risk. We are now in a much better environment for insurance companies.

SELL

Significant dividend but this is a company that has a cloud over it again. When clients bring it in from outside, he tends to eliminate it. He not sure about their equity oriented investment insurance type plans. On a market, which he expects will be indifferent over the next 3 or 4 months, this stock won’t do very well. Their most recent earnings report was a disappointment. Also the Japan situation might come back and bite them.

COMMENT

You can write calls to lower your risk.

HOLD

Stock has not down well. Just as you think they are heading for a breakout, another issue sideswipes them. Will have to take a write down on their insurance policies in Japan, which was the fastest growing part of their business. Higher interest rates are good for their business and the stock market has improved. Think it has a lot more intrinsic value than the current price. You have to be patient.

TOP PICK

Thinks it could move back up to possibly the $20 level. $16 is the exit price.

DON'T BUY

Not positive on this one. Sold his holdings when he discovered it was really a leverage on the US stock market and US bond market interest rates. Would rather buy a life insurance company for their business, not their exposure to interest rates or the stock market.

PAST TOP PICK

(A Top Pick Apr 1/10. Down 11.26%.) Deploying its capital properly.

PAST TOP PICK

(Top Pick Apr 19/10, Down 10.42%) There is a bit of headwind at $19. Weak today because of a story in the paper today. This stock deserves a higher multiple. In 18-24 months they should be in good enough shape to raise the dividend again.

PAST TOP PICK

(A Top Pick Aug 19/10. Up 20.71%.) Technically it should go higher. Likes the sector.

BUY

Within a year you could see this stock north of $10. Solidified balance sheet, have all the capital they need. They have more credibility here. Delivered better numbers the last two quarters. Good international diversification. It’s the high-risk play in the financials.

BUY

$24 model price. He still recommends it. Add on any dips.

PAST TOP PICK

(Top Pick Mar 16/10, Down 13.90%) Still likes it. Thinks as interest rates and bond yields go up, they will make much more from assets under management. Doesn’t think their interests in Japan are material to their results. Investors are unduly negative on the stock.

DON'T BUY

Stock has been struggling for the last little while. Resistance at current levels. Out of the period of seasonal strength. Between Oct and Jan is it’s strong time. Different than banks, which are Feb to May. Stay away for now.

Showing 1,321 to 1,335 of 2,283 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)